Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Shares of Green Giant Inc. GGE fell sharply in pre-market trading after announcing a proposed public offering.

Green Giant shares dipped 37.1% to $0.1599 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

NextPlay Technologies, Inc. NXTP shares rose 62.8% to $0.6841 in pre-market trading. NextPlay Technologies recently received notice from Nasdaq stating that it did not comply with listing rule.
Onconova Therapeutics, Inc. ONTX shares gained 29.3% to $0.83 in pre-market trading. Onconova Therapeutics' preclinical narazaciclib data at SABCS highlighted differentiated anti-tumor activity v. other CDK4/6i's.
Macy's, Inc. M rose 19.1% to $20.71 in pre-market trading. An investor consortium has tabled a $5.8 billion bid to acquire Macy's, in an attempt to privatize the iconic department store chain.
AcelRx Pharmaceuticals, Inc. ACRX shares rose 17.7% to $0.8576 in pre-market trading after falling more than 4% on Friday.
NaaS Technology Inc. NAAS gained 14.9% to $2.39 in pre-market trading. NaaS Technology recently announced termination of proposed Charge Amps acquisition.
Corvus Pharmaceuticals, Inc.CRVS gained 14.6% to $2.20 in pre-market trading. Corvus Pharmaceuticals presented new interim soquelitinib data from its Phase 1/1b T Cell lymphoma trial.
NuZee, Inc. NUZE shares surged 12.1% to $2.69 in pre-market trading after declining 10% on Friday.
The Cigna Group CI shares gained 11.6% to $288.88 in pre-market trading. Cigna has withdrawn from its proposed merger with Humana Inc. HUM.
Processa Pharmaceuticals, Inc. PCSA shares rose 11.5% to $0.85 in pre-market trading after falling over 5% on Friday.
JanOne Inc. JAN shares climbed 8.8% to $0.58 in pre-market trading after jumping 14% on Friday.

Losers

RiskOn International, Inc. ROI shares fell 25.9% to $0.1401 in pre-market trading. RiskOn International recently said Kurt Flygare has been appointed Chief Executive Officer of GuyCare Management, Inc., a subsidiary of GuyCare, Inc.
Near Intelligence, Inc. NIR shares fell 21.1% to $0.12 in pre-market trading. Near Intelligence filed for Chapter 11 protection and entered into agreement to sell its business.
iSun, Inc. ISUN shares fell 20.8% to $0.1520 in pre-market trading after declining around 7% on Friday.
X4 Pharmaceuticals, Inc. XFOR fell 17.6% to $0.7248 in pre-market trading. X4 Pharmaceuticals announced presentation of additional data from mavorixafor Phase 2 trial in chronic neutropenia at ASH 2023.
Purple Biotech Ltd. PPBT shares fell 17.5% to $0.9160 in pre-market trading.
Biomea Fusion, Inc. BMEA shares fell 17.2% to $13.99 in pre-market trading. Biomea Fusion announced near doubling the percentage of patients with durable HbA1c reduction in the 200 mg dose cohorts.
eFFECTOR Therapeutics, Inc. EFTR fell 15.1% to $0.4412 in pre-market trading. eFFECTOR Therapeutics, on Friday, announced new interim data from dose escalation and Phase 2 expansion cohorts of a Phase 1/2 study of zotatifin in patients with estrogen receptor positive (ER+) metastatic breast cancer.
African Agriculture Holdings Inc. AAGR fell 12.6% to $2.01 in pre-market trading after dipping 49% on Friday.
Cyngn Inc. CYN fell 9.5% to $0.1918 in pre-market. Cyngn shares fell 47% on Friday after the company announced pricing of a $5 million public offering of common stock.